DK0972520T3 - Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52 - Google Patents

Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52

Info

Publication number
DK0972520T3
DK0972520T3 DK98901044T DK98901044T DK0972520T3 DK 0972520 T3 DK0972520 T3 DK 0972520T3 DK 98901044 T DK98901044 T DK 98901044T DK 98901044 T DK98901044 T DK 98901044T DK 0972520 T3 DK0972520 T3 DK 0972520T3
Authority
DK
Denmark
Prior art keywords
freeze
bone morphogenetic
morphogenetic protein
human bone
dried composition
Prior art date
Application number
DK98901044T
Other languages
Danish (da)
English (en)
Inventor
Mitsuko Inagaki
Hideki Hoechst Marion Ichikawa
Original Assignee
Bioph Biotech Entw Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioph Biotech Entw Pharm Gmbh filed Critical Bioph Biotech Entw Pharm Gmbh
Application granted granted Critical
Publication of DK0972520T3 publication Critical patent/DK0972520T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98901044T 1997-01-30 1998-01-29 Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52 DK0972520T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1634997 1997-01-30
PCT/JP1998/000371 WO1998033514A1 (fr) 1997-01-30 1998-01-29 Composition lyophilisee de mp52 humaine de proteines morphogenetiques osseuses

Publications (1)

Publication Number Publication Date
DK0972520T3 true DK0972520T3 (da) 2005-12-19

Family

ID=11913900

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98901044T DK0972520T3 (da) 1997-01-30 1998-01-29 Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52

Country Status (22)

Country Link
EP (1) EP0972520B9 (fr)
JP (1) JP4209948B2 (fr)
KR (1) KR100548107B1 (fr)
CN (1) CN1152712C (fr)
AP (1) AP983A (fr)
AT (1) ATE302021T1 (fr)
AU (1) AU737595B2 (fr)
BR (1) BR9807537B1 (fr)
CA (1) CA2278546C (fr)
DE (1) DE69831223T9 (fr)
DK (1) DK0972520T3 (fr)
EA (1) EA001579B1 (fr)
ES (1) ES2244043T3 (fr)
HU (1) HU226554B1 (fr)
IL (2) IL130967A0 (fr)
NO (1) NO322334B1 (fr)
NZ (1) NZ336509A (fr)
PL (1) PL189381B1 (fr)
RS (1) RS49691B (fr)
SI (1) SI0972520T1 (fr)
TR (1) TR199901832T2 (fr)
WO (1) WO1998033514A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4388602B2 (ja) † 1997-02-07 2009-12-24 ストライカー コーポレイション マトリクスを含まない骨形成デバイス、移植片、およびその使用方法
WO2003030873A1 (fr) * 2001-10-09 2003-04-17 Cellfactors Plc Produit biologique therapeutique et procede de formation de nouvel os vascularise
ES2247423T5 (es) 2001-11-19 2015-12-30 Scil Technology Gmbh Método de producción de un dispositivo recubierto homogéneamente que tiene propiedades osteoinductoras y osteoconductoras
ATE322916T1 (de) 2002-09-10 2006-04-15 Scil Technology Gmbh Unter verringerter sauerstoffkonzentration mit einem osteoinduktiven protein beschichtetes metallimplantat
EP1651272A1 (fr) * 2003-08-05 2006-05-03 Fuji Photo Film B.V. Utilisation de gelatine recombinante ou synthetique comme stabilisateur de vaccins
EP1685160A1 (fr) * 2003-11-10 2006-08-02 Arriva-Prometic Inc. Preparation seche de alpha 1-antitrypsine humaine obtenue par recombinaison
ATE478008T1 (de) 2004-03-10 2010-09-15 Scil Technology Gmbh Überzogene implantate, ihre herstellung und verwendung davon
US20160344677A1 (en) 2015-05-22 2016-11-24 Microsoft Technology Licensing, Llc Unified messaging platform for providing interactive semantic objects
US10216709B2 (en) 2015-05-22 2019-02-26 Microsoft Technology Licensing, Llc Unified messaging platform and interface for providing inline replies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080879B1 (fr) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Composition pharmaceutique contenant de l'interféron stabilisé
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
DE69213739T2 (de) * 1991-06-21 1997-02-20 Genetics Institute, Inc., Cambridge, Mass. Osteogene proteine enthaltende arzneimittel
JP2966592B2 (ja) * 1991-07-20 1999-10-25 萩原 義秀 安定化されたヒトモノクローナル抗体製剤
DK0625989T3 (da) * 1992-02-12 2000-06-26 Bioph Biotech Entw Pharm Gmbh DNA-sekvenser kodende for hidtil ukendte vækst-/differentieringsfaktorer
CA2093836A1 (fr) * 1992-04-24 1993-10-25 Wayne Gombotz Systeme biodegradable d'administration du tgf-.beta.pour la regenerat ion osseuse
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
PT814841E (pt) * 1995-03-21 2002-03-28 Applied Research Systems Formulacoes liquidas de hcg
WO1996033215A1 (fr) * 1995-04-19 1996-10-24 Hoechst Pharmaceuticals & Chemicals K.K. Proteine nouvelle et son procede de fabrication

Also Published As

Publication number Publication date
AP9901602A0 (en) 1999-09-30
PL334852A1 (en) 2000-03-27
BR9807537B1 (pt) 2009-01-13
WO1998033514A1 (fr) 1998-08-06
AU737595B2 (en) 2001-08-23
NO322334B1 (no) 2006-09-18
EA001579B1 (ru) 2001-06-25
NZ336509A (en) 2001-03-30
JP4209948B2 (ja) 2009-01-14
CN1244127A (zh) 2000-02-09
AU5679198A (en) 1998-08-25
DE69831223D1 (de) 2005-09-22
AP983A (en) 2001-07-16
CA2278546C (fr) 2008-04-01
NO993702D0 (no) 1999-07-29
DE69831223T9 (de) 2006-12-07
EP0972520B9 (fr) 2006-03-22
PL189381B1 (pl) 2005-07-29
EP0972520B1 (fr) 2005-08-17
HU226554B1 (en) 2009-03-30
TR199901832T2 (xx) 1999-12-21
DE69831223T2 (de) 2006-02-16
EA199900694A1 (ru) 2000-04-24
BR9807537A (pt) 2000-03-21
IL130967A0 (en) 2001-01-28
CN1152712C (zh) 2004-06-09
ATE302021T1 (de) 2005-09-15
CA2278546A1 (fr) 1998-08-06
RS49691B (sr) 2007-12-31
NO993702L (no) 1999-09-29
IL130967A (en) 2006-12-10
YU34999A (sh) 2002-08-12
SI0972520T1 (sl) 2006-02-28
EP0972520A1 (fr) 2000-01-19
HUP0002386A3 (en) 2002-09-30
EP0972520A4 (fr) 2002-11-05
ES2244043T3 (es) 2005-12-01
KR100548107B1 (ko) 2006-02-02
HUP0002386A2 (hu) 2000-11-28
KR20000070586A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
NO991271D0 (no) Benmorfogenetiske Protein-16-sammensetninger (BMP-16)
EP1095159A4 (fr) Proteine morphogenetique osseuse
DE69715264D1 (de) Knochenprothese
DE69722320D1 (de) Skelettimplantat
FI960809L (fi) Hermoregeneraatio käyttäen ihmisen luun morfogeneettisiä proteiineja
DE69624672D1 (de) Wirbelsäulenimplantat
NO965208D0 (no) Benprotese
FI962349L (fi) Luun morfogeneettisten proteiinien mutantit
DE69630933D1 (de) Hohle Knochenprothese mit angepasster Flexibilität
FR2787020B1 (fr) Implant intervertebral
FR2769495B1 (fr) Prothese de genou
DE69715348D1 (de) Hüftgelenkprothese
FR2759576B1 (fr) Implant de sclero-keratectomie pre-descemetique
FR2722980B1 (fr) Implant vertebral inter-epineux
FR2743716B1 (fr) Prothese tibiale
DK0875252T3 (da) Formuleringer af aktiveret protein C
BR9701466A (pt) Implante de área
MA26545A1 (fr) Procedes de cicatrisation des os
DE19681408D2 (de) Additionsvernetzende 2-Komponenten-Siliconmaterialien
PT907364E (pt) Composicao farmaceutica de libertacao sustida
DE59809723D1 (de) Antibiotikumhaltige knochenzementpaste
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
DK0972520T3 (da) Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52
FR2767062B1 (fr) Composition comprenant de la propolis
FR2751528B1 (fr) Prothese de hanche